Canada Enteral Nutrition Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Disease Indication (Orthopedic Disorders, Cardiovascular Disorders, Oncology, Neurological Disorders, and Others), Formula Type (Standard Formulas, Peptide Formulas, and Specialized Formulas), Route of Administration (Oral and Tube Feed), and End User (Long Term Care Facilities, Hospitals, and Others)

The Canada enteral nutrition market size is expected to grow from CA$ 514.33 million in 2023 to CA$ 817.11 million by 2031; the market is estimated to register a CAGR of 6.0% from 2023 to 2031.

Enteral nutrition refers to any method of feeding that involves the gastrointestinal (GI) tract to deliver nutrition for fulfilling an individual’s caloric requirements. It can include a normal oral diet, liquid supplements, or delivery using a tube (tube feeding). Enteral nutrition is necessary for patients whose energy and nutritional needs cannot be met by a regular food intake. The Canada enteral nutrition market report emphasizes the key factors driving the market and depicts the developments of prominent players.

Key factors bolstering the Canada enteral nutrition market include a surge in the prevalence of cachexia and related disorders and a rise in the prevalence of gastrointestinal diseases. Further, the specific formulations and plant-based nutrition products are expected to bring new Canada enteral nutrition market trends in the coming years.

Growth Drivers and Restraints:

The Canadian Mental Health Association celebrates Eating Disorder Awareness Week by wearing purple on February 1, Every year. Cachexia, anorexia, and eating disorders are related in a way that highlights the complex interactions between physiological, psychological, and metabolic aspects. Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. In people with underlying medical disorders, anorexia (a chronic lack of appetite or reduced food intake) may play a role in the onset or aggravation of cachexia. Reduced calorie intake in anorexic patients further hampers their metabolic capacity to preserve muscle mass, store vital nutrients, and attain general metabolic equilibrium, subsequently accelerating the development of cachexia. According to the National Initiative for Eating Disorders, as of 2023, anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), avoidance restrictive food intake disorder (ARFID), and otherwise specified feeding and eating disorder (OSFED) affect approximately 1 million Canadians who have been diagnosed with an eating disorder. Additionally, according to the Canadian Community Health Survey, 1.8% of women aged 65 or more and 2.6% of women from the age group of 50–64 reported having an eating disorder. Thus, with the burgeoning incidence of cachexia, anorexia, and eating disorders—collaborative efforts, awareness initiatives, and implementation of tailored interventions that target both the physical and psychological aspects of the abovementioned conditions support the Canada enteral nutrition market growth.

For many years, the enteral nutrition method has been in use to feed patients who are unable or unwilling to consume food in quantities sufficient for their daily needs. However, the method may lead to various complications due to the techniques applied. When a wide bore tube is used for feeding, the size and rigidity of the tube tend to produce inflammation and irritation. The tube can also encourage gastroesophageal reflux. Fine-bore tubes are prone to coil up in the oropharynx region or to wander off course into the trachea during the insertion process, particularly since the patients are unconscious during the insertion process. Owing to the risk of misplacement, it is important to ensure the correct positioning of a tube before feeding, as it may adversely affect the aspiration in the stomach if not placed properly. These are the mechanical or tube-related aspects that limit the adoption of enteral nutrition methods.

Further, enteral feeding may be followed by nausea, vomiting, diarrhea, constipation, and many gastrointestinal complications. According to Clinical Nutrition Espen, 20% of the total patients on enteral nutrition suffer from nausea, vomiting, bloating, and abdominal cramps. Diarrhea is the most common gastrointestinal complication caused by enteral nutrition, occurring within a wide range of 2–63%. Dehydration, hyperglycemia, electrolyte abnormalities, vitamin and trace element deficiencies, liver function abnormalities, and other metabolic abnormalities may arise during enteral feeding due to the imprudent choice of feed and lack of adequate monitoring. Thus, mechanical complications, gastrointestinal complications, metabolic complications, etc., hinder the Canada enteral nutrition market growth.

Canada Enteral Nutrition MarketReport Scope

Canada Enteral Nutrition Market Report Scope

The List of Companies - Canada Enteral Nutrition Market

1. Nestle SA
2. Abbott Laboratories
3. Fresenius Medical Care AG & Co KgaA
4. Koninklijke DSM NV
5. B Barun SE

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Canada Enteral Nutrition Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Canada Enteral Nutrition Market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the Canada Enteral Nutrition Market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.